Delsys Pharmaceutical Corporation
Latest round
- Series B
Last raised
- Sep 1998
Total raised
- $15M
Investors
- 1
About Delsys Pharmaceutical Corporation
Founded in 1995, Delsys Pharmaceutical Corporation is a researcher and developer of dry powder handling technology for the development and manufacture of solid oral dosage forms of a number of drugs.
Who invested in Delsys Pharmaceutical Corporation
1 investor across 1 round
See all investors in Delsys Pharmaceutical Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Sep 1, 1998
Amount
$15M
Investors
Questions about Delsys Pharmaceutical Corporation
Who invested in Delsys Pharmaceutical Corporation?
Delsys Pharmaceutical Corporation has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Delsys Pharmaceutical Corporation raised?
Delsys Pharmaceutical Corporation has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Delsys Pharmaceutical Corporation last raise money?
Delsys Pharmaceutical Corporation's most recent round on record is a Series B, in Sep 1998.
What does Delsys Pharmaceutical Corporation do?
Founded in 1995, Delsys Pharmaceutical Corporation is a researcher and developer of dry powder handling technology for the development and manufacture of solid oral dosage forms of a number of drugs.
Where is Delsys Pharmaceutical Corporation headquartered?
Delsys Pharmaceutical Corporation is headquartered in US.
Which VCs invest in companies like Delsys Pharmaceutical Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Delsys Pharmaceutical Corporation's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Delsys Pharmaceutical Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.